In a recent speech, a senior official at the U.S. Department of Justice Antitrust Division noted that “in U.S. antitrust enforcement and competition policy, there is no more important question than what can we do to safeguard...more
11/15/2023
/ Anti-Competitive ,
Antitrust Division ,
Antitrust Violations ,
Consumer Protection Laws ,
Continuing Legal Education ,
Department of Justice (DOJ) ,
Drug Pricing ,
Enforcement Actions ,
Enforcement Guidance ,
Federal Trade Commission (FTC) ,
Health Care Providers ,
Healthcare Fraud ,
Merger Reviews ,
Opioid ,
Pharmaceutical Industry ,
Prescription Drugs ,
State Attorneys General ,
Unfair or Deceptive Trade Practices ,
Webinars